Research Overview
From tuftsin to Selank
Tuftsin is a naturally occurring tetrapeptide released from the heavy chain of immunoglobulin G and long studied for its effects on phagocyte activity. Its extremely short half-life limited experimental usefulness, so researchers appended Pro-Gly-Pro to produce Selank, a heptapeptide with greater resistance to enzymatic cleavage while retaining the tuftsin recognition motif.
Behavioral and neurochemical models
Rodent studies have used elevated plus-maze, open-field and conflict paradigms to examine anxiety-like behavior after Selank administration. Reported mechanistic correlates include changes in GABA-A receptor subunit expression, altered serotonin and noradrenaline metabolism in the brainstem and hippocampus, and shifts in enkephalin-degrading enzyme activity — the last being one of the more distinctive findings in the literature.
Immune and cytokine research
- Studies measuring interleukin-6 and other cytokine levels in blood and lymphocyte cultures
- Work examining T-helper balance and macrophage-associated markers, following tuftsin's known immune role
- Gene expression analyses in peripheral blood mononuclear cells reporting changes across inflammation-related clusters
Neurotrophic and gene expression endpoints
Several groups have reported changes in BDNF-related transcripts in rodent hippocampus after repeated administration, and transcriptome-level studies describe broad but modest shifts rather than a single dominant pathway. This pattern is common to the regulatory peptide class and is one reason mechanistic conclusions remain provisional.
Evidence status
Analytical characterization
Because the Selank sequence contains no aromatic residues, laboratories typically rely on low-wavelength UV detection or mass-spectrometric quantification rather than 280 nm absorbance when developing assays. Net peptide content and residual counterion should be checked against the certificate of analysis when normalizing stock concentrations between lots.
